China Shenghuo Pharmaceutical (KUN)
China Shenghuo Pharmaceutical Profit Margin: 3.50%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
KUN Profit Margin Rankings
| Overall | 44th percentile | 2459 of 4397 |
| Sector | 60th percentile | 184 of 469 in Healthcare |
| Industry | 25th percentile | 15 of 20 in Drug Manufacturers - Major |
KUN Profit Margin Range, Past 5 Years
| Minimum | -46.44% | Jun 2009 |
| Maximum | 20.73% | Jun 2007 |
| Average | -7.09% |
About Profit Margin
Profit margin represents the percentage of revenue that a company keeps as profit after accounting for fixed and variable costs. It is calculated by dividing net income by revenue. The profit margin is mainly used for internal comparisons, because acceptable profit margins vary between industries. In general, narrow profit margins indicate increased volatility. For companies with significant fixed costs, wide profit margins reduce the risk that a decline in sales will cause a net profit loss.
Displayed as a percentage, profit margin can be thought as the amount of profit that a company keeps per dollar of revenue. For example, if a company has a profit margin of 43%, the company keeps $.43 of each dollar of revenue.
Learn More
You may also be interested in these KUN related companies
KUN News
URGENT: $KUN filed to delay releasing quarterly earnings results (SEC Filing Form NT 10Q) http://stks.co/3pg2
about 15 days ago by MarketBrief
about 15 days ago by MarketBrief
Ceradyne, San Juan Basin Royalty Among Stocks falling to Annual Lows Wednesday
Apr 25, 4:32PM Fox Business
Apr 25, 4:32PM Fox Business
China Shenghuo Pharmaceutical Receives Opinion with Going Concern Qualification from its Auditor
Apr 05, 9:00PM PR Newswire
Apr 05, 9:00PM PR Newswire
China Shenghuo Pharmaceutical Reports Financial Results for the Full Year 2011
Mar 30, 2:09PM PR Newswire
Mar 30, 2:09PM PR Newswire
China Shenghuo Pharmaceutical Reports Financial Results for the Third Quarter of 2011
Nov 14, 4:17PM PR Newswire
Nov 14, 4:17PM PR Newswire
China Shenghuo Pharmaceutical Holdings, Inc. Reports Financial Results for the Second Quarter of 2011
Aug 16, 12:31AM PR Newswire
Aug 16, 12:31AM PR Newswire
China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011
May 16, 9:00PM PR Newswire
May 16, 9:00PM PR Newswire
China Shenghuo Pharmaceutical Reports Financial Results for the Full Year 2010
Mar 30, 8:30PM PR Newswire
Mar 30, 8:30PM PR Newswire
China Shenghuo Pharmaceutical's Lixuwang Trademark Awarded Chinese Well-Known Trademark Honor
Jan 24, 2:45AM PR Newswire
Jan 24, 2:45AM PR Newswire
$KUN is up .40 on no news the stock trading on a volume of 450k and has a new 52 week high
about 498 days ago by latestbusinessn
about 498 days ago by latestbusinessn
$ONP risk reward is huge .How many of these China pumps have we seen blowup.I had 2 a couple years ago $KUN and China Lighting
about 698 days ago by Detroitblues
about 698 days ago by Detroitblues
$SQNM overnight gapper on ridiculous move, also watching $KUN closely which looks like controlled buying
about 1086 days ago by SoberStocks
about 1086 days ago by SoberStocks
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| KUN | 0.1428 | +0.00 | +0.00% | 2.810M |
| KUB | 41.97 | +0.05 | +0.12% | 10.53B |
| KTOS | 5.395 | -0.14 | -2.44% | 179.61M |
| KTF | 14.36 | +0.08 | +0.56% | |
| KTEC | 9.75 | -0.19 | -1.91% | 53.18M |
| KTCC | 10.51 | -0.21 | -1.96% | 112.02M |
| KT | 11.73 | -0.11 | -0.93% | 5.761B |
| KSWS | 2.76 | +0.01 | +0.36% | 97.90M |
| KSW | 3.89 | -0.06 | -1.52% | 24.78M |
| KSU | 64.33 | -2.31 | -3.47% | 7.328B |
